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Introduction
The incidence of complete Achilles tendon rupture is 18 per 100 000 patient-years1 and is usually
diagnosed clinically by GPs. The extent of clinical misdiagnosis is unknown in Norway, but may be
high.2 This is important as delayed treatment has unfavourable consequences.1,3 We report how a
GP, with no clinical ultrasound experience, recorded images with a pocket-sized ultrasound device
(PSUD) under supervision to confirm a complete Achilles tendon rupture. This could present a new
indication for GP ultrasound.
Case report
A 36-year-old man experienced acute pain above the right heel accompanied by an audible snap
while sprinting. He immediately had difficulty walking and 3 hours later consulted an on-call GP. Pos-
terior ankle swelling with a tender depression 3 cm proximal to the calcaneum was found. Active
plantar flexion against resistance was weak and Simmonds–Thompson test was ‘partially positive’ on
applying a strong calf-squeeze. Based on these findings, calf muscle rupture was diagnosed as the
Achilles tendon was thought to be intact. The patient was advised to elevate the foot and wait 2
weeks for improvement. Two days later a second GP, who was aware of a history of an audible snap,
considered complete tendon rupture and reexamined the patient. Findings included an absent right
heel raise due to weakness, minimal active plantar flexion against gravity and lying prone, significant
right ankle swelling without bruising, and an altered angle of declination. Palpation elicited no ankle
bony tenderness, yet a painful gap was identified 6 cm proximal from the calcaneal attachment,
along the line of the Achilles tendon. Simmonds–Thompson’s test was clearly positive. The positive
Simmond’s triad indicated a clinical diagnosis of complete rupture of the Achilles tendon.
A 3.4–8 MHz linear array probe PSUD (VScan dual probe, GE Healthcare), set at a depth of
3.5 cm, was used under the supervision of a rheumatologist experienced in ultrasound. The tendon
was enlarged from 1 cm to 6 cm above the calcaneal insertion, where a clear gap was seen
(Figure 1). Two hours later a radiologist-performed ultrasound (LOGIQ E9, GE Healthcare)
and reported an enlarged distal tendon and a complete rupture at 5–6 cm from the calcaneal attach-
ment, creating a 2.7 cm blood-filled gap (Figure 2). Surgical exploration 8 days post-injury found a
complete Achilles tendon rupture ‘5–10 cm above the ankle joint’.
Discussion
Tromsø Hospital serves a large area with a population of approximately 160 000. Between 2010–
2014 an average of 21 patients per year were referred by their GP for suspected Achilles rupture.
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Introduction
Last summer our small medical team visit the Calais ’Jungle’. Since that time muc has hanged
and the camp is being demolished and by the time this article is read, it will probably be long gone.
Some you gsters are finally being brought to the UK under the ’Dubs’ amendment. H wever, once
this camp is clear d it will not solve the ongoing flight of refugees from war torn areas: other camps
are already appearing.
July 2016
A young Afghan man caught his finger on a sharp point while trying to cross a barbed wire fence.
The finger was partially degloved. He attended the local hospital, where they placed a few sutures,
but now, 2 weeks later, the skin is necrotic and the underlying tissue looks infected. He is in danger
of losing his finger.
A middle-aged Sudanese man has been having rigors and is generally unwell. He says it is similar
to when he last had malaria.
A young Ukrainian woman complains of lower back pain and urinary frequency.
Th paths of these three people may never have crossed; yet here they are, denizens of the Calais
Jungle. They turn up to a makeshift primary care ‘clinic’ that we set up in the heart of the unofficial
refugee camp on weekend in July 2016.
With only basic medical supplies, we are immediately ch llenged by what we see. How can w
arrange sec dary care for the young Afghan in danger of losing his finger? We try to persuade him
to return to the original local hospital, but is reluctant. It was not a good experience for him t
first time round.
With the other two patients, it is easier. They can attend the Salam clinic run by a loc l association
during w ekdays. Later, we receive word that malaria has been confirmed in our Su anese patient.
More people arrive, presenting with scabies, rat bites, tinea, chest infections, and wheezing from
inhaling smok from fires lit to cook keep warm in their t nts t night. We examin a severely
malnourish d 2-year-old boy. We meet everal of the ca ’s 600 unaccompanied children, at grave
risk of sexual exploitation. We learn that there i inadequate safeguarding in place to prot ct them.
A young Eritrean man comes i worried about his eye. H has sustained direct ocular trauma from a
rubber bullet, and will never see normally again out of that eye. We see aematomas from olice
batons, and hear about children being exposed to tear gas again and again (Figure 1).
The reality
These ar no ordinary patients. They h ve travelled far from home to escape war, poverty, and mis-
ery. They have ndured personal odysseys to get here, experienced untold hardships, and suffered
unimaginable privations. Many have survived the loss of their families, torture, and rape. Their jour-
neys over, for the moment at least, they must make their homes in the Calais Jungle. Their new shel-
ters are in many cases mere tarpaulin covers, and their new beds just rugs on the ground. They own
next to nothing. Ther is little for them to do, besides use their ingenuity to cross the English Chan-
nel in search of a better life. They are vuln rabl to xploitation, crime, injury, and disease. Poten-
tially violent clashes with local police, with other ethnic groups resident in the Jungle, or local far
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Ab tract
Background: Atopic ecze a, asthma, and allergic r initis (AR) create a serious burden on general
practice resources.
Aim: To investigate the use of general practice resources (that is, consultation visits, telephone
contacts, and home visits) in children with physician-diagnosed atopic disorders (ADs).
Design & setting: In a nested index-control study design, all children (here defined as individuals
aged 2–18 years) listed in a representative general practice database were selected in 2014.
Method: Children diagnosed with ADs were tched on age and sex with non-atopic controls
within the same practice. For all the different groups, the number and frequency of children
contacting the GP were calculated.
R sults: Of th children with atopic eczema ( = 15 202), 80% consulted t GP in 2014 (controls =
67%). Of the childr n with asthma (n = 7754), 80% consult d he GP (control = 65%), and for
childre with AR (n = 6710), this was 82% (controls = 66%). Of the childre with all three ADs, 91%
consulted the GP (contr ls = 68%). O aver g , a child with atopic eczema contacted the GP 2.8
times/year (controls = 1.9); for children with asthma, the contact f qu ncy was 3.0 (controls = 1.9);
nd for AR, 3.2 (controls = 1.9). For children wit all three ADs, the cont ct frequency was 4.3
cont ls = 2.0). Consultations rel ted to the ADs investig ted only xplain a smaller part of the
increased healthcar utilisation in atopic children.
Con lusion: Atopic children use more general practice resources compared to non-atopic children,
yet fr quently for orbidity or other health-related qu stio s not related to one of the ADs.
How this fits in
Atopic children use significantly more primary healthcare resources compared with non-atopic chil-
dren. Remarkably, consultations related to specific ADs only explain a smaller part of the increased
healthcare utilisation in atopic children. The majority of the excess consultations were therefore
related to morbidity not diagnosed as one of the specific ADs.
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Introduction
Atopic eczema, asthma, and AR are among the most common chronic disorders in children.1,2 They
are often referred to as ‘atopic disorders’ and represent a burden on general practice resources.
However, the extent of this burdern is largely unknown. A recent study, based on health surveys,
showed that children with atopic eczema, asthma, and AR used more healthcare resources than chil-
dren without these disorders.3 When studying healthcare utilisation in a general practice setting, a
diagnosis based on a physician’s assessment, such as that of a GP, provides more realistic results
than questionnaire-based diagnoses, and therefore should be preferred.1 Previous studies examining
healthcare utilisation of atopic children were often conducted in different clinical settings (for exam-
ple, birth cohorts). Also, whereas most of the studies on healthcare utilisation have focused on
asthma,3–9 only a few focused on atopic eczema3,10 and AR.3 All these studies demonstrated that
the healthcare utilisation of atopic children is significantly higher compared with non-atopic children.
However, to the authors’ knowledge, no study has examined to what extent this increased use of
healthcare resources reflects extra consultations regarding the ADs, or reflects consultations regard-
ing non-atopic comorbidity (for example, consultations for common symptoms occurring in
childhood).
The present study aimed to quantify the current health burden posed by specific ADs (atopic
eczema, asthma, and AR), on general practice resources, based on electronic health records. Fur-
thermore, a differentiation is made between atopic-related consultations and non-atopic related
consultations.
Method
NIVEL primary care database
Generally, all non-institutionalised residents in the Netherlands are registered in a general practice,
even if they do not contact the GP. Since 2001, NIVEL-Primary Care Database (NIVEL-PCD) includes
routinely extracted data from electronic health records (EHRs) from a representative sample of Dutch
general practices,11 including information about declared encounters, prescribed medication, and
diagnoses. Diagnoses are recorded and classified according to the International Classification of Pri-
mary Care 1 (ICPC-1).12 In 2014, the authors used data from all NIVEL-PCD practices (with 500
listed patients; mean practice size = 2350 patients) with sufficient data quality, fulfilling the following
criteria: complete medical and financial registration of encounters (defined as 46 weeks per year),
and sufficient ICPC-1 coding of diagnostic information (defined as 70% of the recorded encounters
with an ICPC-1 code). An additional requirement was a minimum follow-up of 3 years for an individ-
ual child (that is, data had to be available for 2012–2014), to reduce the risk of registration bias; for
this reason, only data for children aged 2 years are presented here.
Selection of atopic children
Based on a method that is described in detail elsewhere,2 all children with specific ADs (represented
by the ICPC-codes S87: atopic dermatitis, R96: asthma, and R97: AR) were selected on 1 January
2014. In practice, an atopic diagnosis was maintained if (based on available data from EHRs in the
period 2002–2014) the child had 2 contact moments in that episode of care (for S87; R96; R97),
and had received 2 relevant prescriptions. In the Dutch setting, prescriptions are linked with a
code based on the Anatomical Therapeutic Chemical Classification System (ATC), making the identi-
fication of prescriptions possible. For atopic eczema, the ATC code D07 (dermatological corticoste-
roids) was used; for asthma, the ATC code R03 (drugs for obstructive airway diseases) was used; and
for AR, the ATC codes R01AC (nasal preparation of antiallergic agents, excluding corticosteroids),
R01AD (nasal preparation of corticosteroids), and R06 (antihistamines for systemic use) were used.
These medication proxies have been tested by Mulder et al using registered diagnoses as a gold
standard.13 If the child did not meet these criteria, the child was considered not to have that AD. It
was not a requirement that the patient had contacted the GP in 2014 for that specific AD.
Atopic triad
In contrast to the traditional classification of children with atopic eczema, asthma, or AR, a fourth dis-
tinct group of children with all three ADs might exist.1 Therefore, ‘atopic triad’ (AT) episodes were
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developed for research purposes to learn more about this potentially unique group of children. An
AT was only defined when a child was diagnosed with all three ADs (corrected to select cases with a
higher probability of the clinically-relevant disorder), based on available data from EHRs in the
period 2002–2014.
Design
In a nested index-control study design, one matched control patient (no recorded ICPC-1 codes
S87, R96, or R97 ever) within the same general practice was selected for each atopic child, based on
sex and age in 2014. When studying children with atopic eczema, asthma, or AR for this study, only
those children that had one AD were selected. For children with all three atopic disorders, one
matched control patient was also selected.
Statistical analyses
In the Netherlands, a financial declaration is automatically created in the EHRs at the end of every
consultation; that is, consultation visits, telephone contacts, and home visits (the ordering of repeat
medication was excluded). Financial declaration recordings from the year 2014 were therefore used
to determine healthcare utilisation in general practice. Diagnoses were linked with declared encoun-
ters on the same day. If a child consulted the GP for both an atopic-related problem as well as for a
non-atopic-related problem, the declared encounter was considered atopic-related. All patients
aged 2–18 years were selected. Two different epidemiological markers were calculated: firstly, the
percentage of patients consulting the GP in 1 year, as well as the percentage of patients consulting
the GP for the specific AD of interest; and secondly, contact frequency, defined as the number of
declared encounters overall, as well as the number of declared encounters for a specific AD in 1
year.
For the year 2014, healthcare utilisation and contact frequency rates were calculated for atopic
eczema, asthma, AR, and AT in males and females for the age groups 2–6 years, 7–12 years, 13–18
years, and 2–18 years. For the analyses of children with atopic eczema, asthma, or AR, the child was
not diagnosed with any of the other ADs. Statistical differences between the groups were tested
using c2 tests (the percentage of patients consulting) and t-tests (contact frequency). Due to multi-
ple testing, differences were considered statistically significant with P<0.001. All analyses were per-
formed with Stata (version 14.1).
Results
General characteristics
In 2014, 409 312 children were identified from the NIVEL-PCD. From this group, children were iden-
tified fulfilling the selection criteria with: only eczema (n = 15 202); only asthma (n = 7754); only AR
(n = 6710); and AT (n = 555). One control patient was matched for each of these atopic children. For
this study, 307 different general practices were involved. With the exception of atopic eczema
(48.2%), the majority of the children with AD were male: asthma (58.9%), AR (57.9%), and AT
(61.6%).
In both the atopic and non-atopic group, females visited the GP more often compared with
males. When examining age in more detail, males showed an overall decrease in consultation rates
as they became older, whereas females showed a dip in the consultation rate just before adoles-
cence (7–12 years). Both these trends were the same in atopic as well as non-atopic children
(Tables 1 and 2).
Children with only atopic eczema
In 2014, 80% of the children diagnosed with only atopic eczema consulted their GP, compared with
67% in the control group (P<0.001). Of the children with atopic eczema, only 24% consulted their
GP because of their atopic eczema. When examining the contact frequency, children with atopic
eczema consulted their GP on average 2.8 times/year, compared with 1.9 times/year in the control
group (difference 0.9 times/year, P<0.001). The average contact frequency for atopic eczema-
related consultations was only 0.4 times/year; therefore, 0.5 of the additional consultations in a year
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were due to other morbidity or other health-related questions. The differences in contact frequen-
cies are not explained by the few children who consulted their GP very often.
Children with only asthma
In 2014, 80% of the children with only asthma consulted their GP, compared with 65% in the control
group (P<0.001). Only 28% of the asthmatic children had asthma-related consultations with their GP.
Asthmatic children consulted their GP on average 3.0 times/year, compared to 1.9 times/year in the
control group (difference 1.1 times/year, P<0.001). Since an asthmatic child consulted their GP for
asthma-related problems only 0.5 times/year, this implies that an asthmatic child consults the GP 0.6
times/year extra for other morbidity.












No AD AD AD No AD AD AD
Atopic eczema
Male, total 14 662 66 78 22 1.8 2.6 0.3
Male, 2–6 years 6264 72 84 24 2.1 3.0 0.4
Male, 7–12 years 5322 63 75 21 1.6 2.3 0.3
Male, 13–18 years 3076 60 73 23 1.5 2.2 0.3
Female, total 15 742 68 81 26 2.1 3.0 0.4
Female, 2–6 years 5728 71 82 27 2.1 3.0 0.4
Female, 7–12 years 6126 62 77 23 1.7 2.5 0.3
Female, 13–18 years 3888 72 85 31 2.5 3.6 0.5
Total group 30 404 67 80 24 1.9 2.8 0.4
Asthma
Male, total 9132 62 78 27 1.6 2.7 0.5
Male, 2–6 years 2174 72 86 32 2.1 3.4 0.6
Male, 7–12 years 3698 60 78 28 1.4 2.5 0.5
Male, 13–18 years 3260 59 73 23 1.5 2.3 0.4
Female, total 6376 69 83 30 2.2 3.5 0.6
Female, 2–6 years 1440 73 86 35 2.3 3.5 0.7
Female, 7–12 years 2292 63 79 24 1.7 2.7 0.4
Female, 13–18 years 2644 73 85 32 2.5 4.2 0.7
Total group 15 508 65 80 28 1.9 3.0 0.5
AR
Male 7766 62 79 35 1.6 2.7 0.5
Male, 2–6 years 326 75 94 52 2.3 4.4 1.0
Male, 7–12 years 2682 64 82 42 1.6 2.8 0.7
Male, 13–18 years 4758 59 77 30 1.5 2.4 0.4
Female, total 5654 71 87 39 2.4 3.8 0.6
Female, 2–6 years 218 77 95 48 2.2 5.0 0.9
Female, 7–12 years 1608 63 82 41 1.7 3.0 0.7
Female, 13–18 years 3828 74 88 38 2.7 4.1 0.6
Total group 13 420 66 82 37 1.9 3.2 0.6
aP<0.001. AD = atopic disorder. AR = allergic rhinitis.
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Children with only AR
In 2014, 82% of the children diagnosed with only AR consulted their GP (controls = 66%, P<0.001).
Of the children with only AR, 37% consulted their GP because of this condition. Contact frequency
of children with AR was on average 3.2 times/year (control = 1.9 times/year; difference = 1.3 times/
year; P<0.001). This difference is 0.6 times/year due to AR, and 0.7 times/year due to other reasons.
Children with AT
In 2014, only a small group of children were identified as being diagnosed with AT, of which 91%
consulted their GP (controls = 68%, P<0.001): 32% of these children consulted their GP in 2014 for
atopic eczema, 37% for asthma, and 37% for AR. The contact frequency of children with AT was on
average 4.3 times/year, compared with 2.0 times/year in the control group (P<0.001). The contact
frequency for atopic eczema-related consultations was 0.5 times/year, for asthma-related consulta-
tions 0.7, and for AR 0.6. Therefore, of the excess consultation rate of 2.3 times/year, 1.8 is caused
by AT, and 0.5 is due to other reasons.
Discussion
Summary
This study is the first to examine healthcare utilisation of all three specific ADs in a general practice
setting, using physician-based diagnoses. This study contributes new and detailed data on the
increased healthcare utilisation associated with atopic eczema, asthma, and AR in a sample of Dutch
children selected from a representative general practice database. Children with ADs use more gen-
eral practice resources compared with children without ADs. Remarkably, the excess consultation
rates are mainly due to non-atopic symptoms and diagnoses (that is, those symptoms and diagnoses
not labelled as any of the studied ADs). In children with AT, a comparable excess rate (0.5 times/
year) is caused by this non-atopic morbidity, suggesting that excess morbidity occurred in all four
groups at an equal frequency. Nevertheless, children with AT consulted the GP most frequently, indi-
cating that this might be a unique group. ADs did not explain the trends regarding age and sex that
were observed in the present study.
Strengths and limitations
The present study used an extensive and representative primary care database; the number of
included children gives this study substantial power. Data from databases are generally considered
reliable and there is no risk of recall bias. Furthermore, the present study included only practices
with complete data regarding declared consultations. Using physician-based diagnosis of ADs and
selecting cases with a higher probability of a clinically-relevant disorder (2 consultations and 2 rel-
evant prescriptions) made this study highly relevant for studying healthcare utilisation in the general
practice setting.
In the Dutch healthcare system, a payment for review for asthmatic children does not yet exist.
Most, if not all, consultations in this healthcare system will be ‘family-initiated’. These results might
therefore be more applicable to countries which also do not have reviews as part of a quality out-
come framework.
Some limitations also need to be discussed. The present study is based on the assumption that
the relevant ICPC-1 codes are not missed; however, this risk cannot be excluded, nor can it be quan-
tified. This study also lacks an objective measure of ADs, such as lung function or allergy tests and
the results of simple questionnaires to measure the severity of the disorder. For both index patients
and controls, the lack of these details could mean that the results were not corrected for an impor-
tant confounder. The study might also have included some children not currently affected, possibly
due to insufficient follow-up by the GP. Finally, although these findings support the hypothesis that
childhood ADs increase healthcare utilisation, the precise comorbidity causing the increased health-
care utilisation was not examined.
Comparison with existing literature
These findings are in agreement with other studies3-10 that also concluded that atopic children uti-
lised more health care; however, this study extended those findings by examining whether the extra
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consultations are a result of a child’s specific AD or are due to other symptoms or diseases. Based
on the present study, <50% of the extra consultations can be explained by atopic eczema, asthma,
and AR-related consultations. Therefore, the remainder of the consultations is attributed to other
symptoms or diseases. Although part of these consultations could still be related to atopy (for exam-
ple, food allergy or symptoms of undiagnosed ADs), non-atopic-related morbidity will most likely
explain an important part of it. It could also be a reflection of parental concern. Future research
might further unravel the precise reasons for the increased healthcare utilisation in primary care;
could possibly look at the overall healthcare burden; and, preferably, could compare ADs with other
chronic conditions in children.
In 2015, a Dutch child (aged 5–17 years) consulted the GP twice a year on average,14 which is in
accordance with the contact frequency of the control groups in the present study and endorses the
conclusions that atopic children utilise more health care due to their atopic constitution. In contrast,
older individuals (aged >85 years) had 13 consultations a year.14 Unfortunately, it is not possible to
compare the healthcare utilisation of atopic children — who are treated mainly by GPs; only a small
number of children will be treated exclusively in secondary care — with other chronic conditions in
paediatric patients. Diabetes mellitus (DM), autoimmune disorders, and other serious chronic dis-
eases in children are treated mainly by specialist physicians, such as paediatricians, since the preva-
lence rates of these diseases are too low for GPs to gain the necessary experience. Therefore,
problems associated with these chronic conditions in children will most likely be handled in second-
ary health care. Healthcare utilisation of children with these chronic conditions in general practice
can therefore not be compared with ADs, which are mostly treated by GPs. However, when compar-
ing healthcare utilisation of children with ADs with that of adult patients with chronic obstructive pul-
monary disease (COPD) and DM, an interesting difference emerges. Of the atopic children, 24–
37% consulted their GP once a year for their specific AD. This is substantially lower compared to the
54% of patients with COPD who consult their GP for COPD-related problems 1 times/year,15 or
even the 85% of patients with DM that consults the GP 1 times/year for this disease.16 The most
likely explanations for this observation is that, in the Netherlands, adult patients with COPD and DM
receive routine follow-up consultations as a result of ‘integrated multidisciplinary care’. Unfortu-
nately, such a follow-up system is not implemented for paediatric patients in general practice. How-
ever, identifying patients with asthma with insufficient follow-up and improving their medication
management in accordance with asthma clinical guidelines is likely to result in lower healthcare
utilisation,5 and may improve the quality of life of these children. The Dutch asthma guideline for
children recommends 1 evaluation/year. 17 As shown by others,18,19 unawareness and undertreat-
ment of asthma and AR is common, and needs to be addressed. The problem of undertreatment
becomes even more relevant when considering, for example, that when AR is undertreated, this can
have a negative impact on asthma control.20,21
Implications for practice
Since the contact frequency for ADs is always <1 times/year, there is evidence that atopic children
do not receive routine follow-up. Most likely, the majority of these consultations will have been fam-
ily-initiated, since it is less likely that a Dutch GP initiates consultations. Considering the evidence of
both overdiagnosis and underdiagnosis of ADs,22,23 the authors suggest that atopic children could
probably benefit from better follow-up, for example, as part of integrated multidisciplinary care, and
thereby be provided with the care they deserve. Therefore, GPs are urged to be more aware of their
atopic paediatric patients and take appropriate action so that they can also benefit from routine fol-
low-up.
In conclusion, atopic children use significantly more primary healthcare resources compared with
non-atopic children. Remarkably, consultations related to ADs only explain a smaller part of the
increased healthcare utilisation in atopic children. The majority of the excess consultations were
therefore related to morbidity not diagnosed as one of the studied ADs.
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